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Long-term Prognostic Significance of Treadmill
Ischemia in "Low-risk" Patients with Coronary
Artery Disease
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was performed at 4 weeks, LV end-diastolic (EDVI) volume (mllm2), Lown-
grade and OT-duration, corrected for heart rate (OTc, ms) were measured at
4 days, 4 weeks, 0.5,1.5, and 3 years by gated SPECT, Holter and 12-channel
ECG, respectively. During an average follow-up of 59.7 months, 16 patients
died (mortality 12.2%, median survival time of 30 months). Death was pro-
ceeded by progressive LV dilation (left figure) and occurred suddenly in 14
of 16 patients (88%). Extend and severity of ventricular arrhythmias, as indi-
cated by a rise of Lawn-grade from 2.8 ± 0.5 to 3.6 ± 0.5, 5.0 ± 0.4, 5.4 ±
0.3 and 5.8 ± 0.2 at 4 days, 4 weeks, 6 months, 1.5 and 3 years, respectively
(p < 0.00001), increased before death. This was associated with a rise of
OTc from 457 ± 6 at 4 days to 480 ± 9 before death (p = 0,01). In contrast,
EDVI (left Figure) and Lown-grade did not rise and OTc even decreased (457
± 8, 456 ± 8, 424 ± 4, 414 ± 5, 399 ± 4) in survivors (p < 0.05). Extend of
LV dilatation correlated with severity of ventricular arrhythmias (right Figure).
Non-survivors did not differ in drug therapy, electrolytes or initial coronary
status and exercise tests were negative. These findings indicate that pro-
gressive LV dilatation (remodeling I may provide a proarrhythmic substrate
for sudden death after Mi, which deserves more detailed analysis.
Patients with stable single or 2-vessel coronary artery disease (CAD) and nor-
mal, or mildly depressed left ventricular function have a good prognosis. We
have investigated the long-term prognostic significance of a positive exercise
test (ExTestl in this population to establish whether it is useful in identifying
a "high-risk" subgroup within a recognised "low-risk" population. Between
1987-94,162 patients with documented single (n = 89) or double (n = 73)
vessel CAD (exclUding left main and proximal left anterior descending CAD),
left ventricular ejection fraction >35% (mean 51 %, range 36-72%) on ra-
dionuclide ventriculography, and an interpretable ExTest were assigned to
receive medical therapy. There were 123 males and 39 females (mean age
60 yrs). A positive ExTest for ischemia was present in 104 (64%) pts. Pts
were followed for a mean period of 49 months (range 6-82 months), during
which time 34 (21 %) had cardiac events (cardiac death n = 3, myocardial
infarction (AMI) n = 14, unstable angina n = 6, elective revascularisation n =
11). Similar proportion of pts with a positive ExTest and a negative ExTest suf-
fered cardiac events (all events, including revascularization) during follow-up
(21 % and 20.7% respectively). Kaplan Meier survival analysis demonstrated
no difference between the groups. Survival analysis also failed to demon-
strate any difference in the incidence of acute cardiac events (cardiac death
and AMI) between positive and negative ExTest groups; of 15 events, 6 (40%)
occurred in those with a positive Extest. Pts with 2-vessel disease suffered
significantly more events than those with I-vessel disease (29% vs 14.6%, P
< 0.05), but there was no difference in acute events (cardiac death and AMI)
between the two subsets. Even in pts with 2-vessel disease, there was no
difference in survival in those with and without a positive ExTest. The data
indicate that although detection of ischemia by exercise testing is useful as
an initial diagnostic tool, once the coronary anatomy and left ventricular func-
tion are known, the presence of ischemia on treadmill exercise is of limited
prognostic value in "low-risk" pts with stable CAD. These findings are consis-
tent with reports demonstrating that acute cardiac events often result from
plaque rupture in non-significantly stenosed vessels.
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Hospital admissions to exclude myocardial ischemia as one possible cause
of unexplained chest pain (CP) are costly and have a low positive diagnostic
yield. This prospective study was performed to determine whether a compre-
hensive emergency department (ED I-based cardiology service provides ac-
curate diagnoses with a significant cost savings. A special cardiology service
providing consultations, exercise testing and echocardiography was used to
evaluate 97 consecutive emergency department patients (pts) (44 male, 53
female) who presented with CP The pts had one or more risk factors for coro-
nary artery disease, a suspicious but atypical CP pattern, and no ECG/enzyme
evidence of acute myocardial injury. To qualify, each pt had to be considered
an appropriate candidate for hospital admission to evaluate CP by the ED
physician. Based on negative exercise testing results performed upon clin-
ical evaluation in the ED, all pts were discharged to continued non-cardiac
ambulatory work-up. Mean cost of the evaluation was $1683 ± $871. A con-
trol group of 36 pts with similar symptoms underwent identical diagnostic
procedures on an in-patient basis. In all cases, myocardial ischemia origin of
the CP was excluded and the pts were discharged to various out-patient ser-
vices. The mean cost of their hospital stay was $6358 ± $1884. We conclude
that comprehensive cardiology service within an emergency department is
a reliable alternative to hospitalization and results in a 74% cost-reduction
for evaluation of a pt with atypical chest pain.
evening. After correcting ischemic time for each patient's simultaneously
measured activity level, a significant circadian fluctuation of ischemic time
was still observed (p < 0.001) with an early morning peak at 6 a.m.
Conclusion: There is an underlying endogenous circadian rhythm of is-
chemic vulnerability, which is independent of exogenous factors. Exogenous
factors are most potent as triggers of ischemia at the time of morning peak
of the endogenous variation in vulnerability for ischemia.
Background: Patients with known coronary artery disease rnay be receiv-
ing inadequate medical therapy prior to referral for percutaneous coronary
revascularization. Methods: To examine the medical treatment of patients re-
ferred for percutaneous coronary revascularization, we analyzed pre-hospital
treatment data and concomitant medical conditions from the CAVEAT I trial.
Results: Of the 1,012 patients referred for revascularization 68.3% had unsta-
ble angina, 17.6% had stable angina, 9.8% had chest pain after myocardial
infarction, and 4.3% were asymptomatic with a positive functional study.
Prior to PTCA or directional atherectomy (DCA), patients had low rates of
treatment with aspirin, nitrates, calcium channel blockers, beta-blockers, and
anti-lipid agents (Table). Pre-hospital medications were associated with the
following conditions: aspirin-none, nitrates-none, calcium channel blockers-
hypertension (p = 0.004) and absence of unstable angina (p = 0.046), beta
blockers-hypertension (p = 0.01), and anti-lipid agents-hyperlipidemia Ip =
0.0001) and number of diseased vessels (p = 0035). Conclusions: These
data strongly indicate that patients referred for percutaneous coronary revas-
cularization have inadequate pre-hospital medical treatment.
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Although left ventricular (LV) dilation after myocardial infarction (Mi) carries
an adverse prognosis, it is unclear whether individual patients indeed die
with progressive remodeling, and how dilation is related to death.
We assessed 131 consecutive asymptomatic patients during 5 years after
uncomplicated first myocardial infarction (Mi). In each, coronary angiography
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The effect of treatment with metoprolol or verapamil was investigated in 809
patients with stable angina pectoris. End points for the study were: death,
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